Banvit Bandirma Vitaminli Yem Sanayii Anonim Sirketi (IST:BANVT)
176.90
+7.90 (4.67%)
At close: Feb 9, 2026
IST:BANVT Income Statement
Financials in millions TRY. Fiscal year is January - December.
Millions TRY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 26,135 | 31,534 | 30,789 | 20,274 | 5,321 | 3,678 | |
Revenue Growth (YoY) | -33.38% | 2.42% | 51.86% | 280.98% | 44.69% | 6.94% |
Cost of Revenue | 25,083 | 24,257 | 27,223 | 20,837 | 4,652 | 3,462 |
Gross Profit | 1,052 | 7,277 | 3,566 | -563.25 | 669.88 | 216.23 |
Selling, General & Admin | 3,186 | 3,060 | 2,379 | 1,585 | 373.58 | 300.4 |
Research & Development | 0.46 | 0.89 | 0.62 | 0.34 | 3.15 | 1.15 |
Other Operating Expenses | -479.85 | -671.43 | -1,135 | -168.86 | -4.73 | -7.65 |
Operating Expenses | 2,707 | 2,389 | 1,245 | 1,417 | 372 | 293.89 |
Operating Income | -1,655 | 4,888 | 2,321 | -1,980 | 297.87 | -77.66 |
Interest Expense | -538.21 | -781.13 | -878.29 | -424.78 | -193.48 | -67.21 |
Interest & Investment Income | 870.28 | 100.48 | 192.84 | 104.25 | 220.44 | 22.43 |
Currency Exchange Gain (Loss) | 694.55 | 609.86 | -2,137 | -576.34 | -167.26 | -45.96 |
Other Non Operating Income (Expenses) | -928.36 | 255.77 | 2,535 | 1,939 | -13.85 | -6.92 |
EBT Excluding Unusual Items | -1,557 | 5,073 | 2,034 | -937.65 | 143.72 | -175.32 |
Gain (Loss) on Sale of Investments | - | - | - | - | -25.78 | -73.73 |
Gain (Loss) on Sale of Assets | -67.08 | 73.6 | - | - | - | - |
Pretax Income | -1,624 | 5,146 | 2,034 | -937.65 | 118.29 | -247.94 |
Income Tax Expense | 199.11 | 1,547 | 587.9 | 14.41 | 23.14 | -48.19 |
Earnings From Continuing Operations | -1,823 | 3,599 | 1,446 | -952.06 | 95.15 | -199.75 |
Earnings From Discontinued Operations | - | - | -71.26 | -30.61 | - | - |
Net Income | -1,823 | 3,599 | 1,374 | -982.67 | 95.15 | -199.75 |
Net Income to Common | -1,823 | 3,599 | 1,374 | -982.67 | 95.15 | -199.75 |
Net Income Growth | - | 161.86% | - | - | - | - |
Shares Outstanding (Basic) | 100 | 100 | 100 | 100 | 100 | 100 |
Shares Outstanding (Diluted) | 100 | 100 | 100 | 100 | 100 | 100 |
EPS (Basic) | -18.22 | 35.98 | 13.74 | -9.82 | 0.95 | -2.00 |
EPS (Diluted) | -18.22 | 35.98 | 13.74 | -9.82 | 0.95 | -2.00 |
EPS Growth | - | 161.86% | - | - | - | - |
Free Cash Flow | -17,737 | -12,477 | -15,812 | -14,440 | -3,450 | -2,197 |
Free Cash Flow Per Share | -177.33 | -124.74 | -158.09 | -144.37 | -34.49 | -21.96 |
Gross Margin | 4.03% | 23.08% | 11.58% | -2.78% | 12.59% | 5.88% |
Operating Margin | -6.33% | 15.50% | 7.54% | -9.77% | 5.60% | -2.11% |
Profit Margin | -6.97% | 11.41% | 4.46% | -4.85% | 1.79% | -5.43% |
Free Cash Flow Margin | -67.87% | -39.57% | -51.36% | -71.23% | -64.83% | -59.74% |
EBITDA | -349.87 | 6,333 | 4,013 | -1,261 | 525.22 | 119.6 |
EBITDA Margin | -1.34% | 20.08% | 13.03% | -6.22% | 9.87% | 3.25% |
D&A For EBITDA | 1,305 | 1,446 | 1,692 | 719.22 | 227.35 | 197.26 |
EBIT | -1,655 | 4,888 | 2,321 | -1,980 | 297.87 | -77.66 |
EBIT Margin | -6.33% | 15.50% | 7.54% | -9.77% | 5.60% | -2.11% |
Effective Tax Rate | - | 30.06% | 28.91% | - | 19.56% | - |
Advertising Expenses | - | 75.11 | 43.73 | 54.27 | 21.92 | 16.38 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.